Grace Therapeutics's total assets for Q3 2024 were $61.22M, a decrease of -6.31% from the previous quarter. GRCE total liabilities were $9.09M for the fiscal quarter, a -1.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.